在中国患有IgA肺部病变的患者中,氧化的血度和影响
Ting Yang1,2, Yaotong Shi1,3, Ye Wang4
1Department of Nephrology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.
Journal of nephrology
|July 24, 2024
概括
氧化 (HCQ) 有效地降低了中国患者免疫球蛋白A脏病 (IgAN) 的蛋白尿. 较高的HCQ血度与更好的治疗结果相关,建立了治疗疗效的最佳范围.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是一种常见的淋巴细胞疾病.
- 对于中国Igan患者,建议使用氧化 (HCQ).
- 血中HCQ度与Igan治疗疗效之间的关系还不清楚.
研究的目的:
- 在中国患者中研究HCQ血度的最佳和有效范围.
- 确定HCQ血度与IGAN治疗效果之间的相关性.
- 评估HCQ在Igan治疗中的安全性和有效性.
主要方法:
- 其中包括73名IGAN患者.
- 三十八名患者接受HCQ加Renin-angiotensin-aldosterone系统抑制剂 (RAASi);35名患者仅接受RAASi.
- 血中HCQ度和24小时蛋白尿被测量在3个月和6个月.
主要成果:
- 在6个月内,HCQ治疗显著降低了蛋白尿症,相比单独使用RAASi.
- 在3个月和6个月后,HCQ组的蛋白尿减少显著增加.
- 3个月和6个月的HCQ血度与疗效正相关 (r=0.428和r=0.48,分别).
- 最佳的HCQ度为418.96 ng/mL (3个月) 和582.48 ng/mL (6个月).
- 没有报告任何严重的不良事件.
结论:
- 氧化可以在中国Igan患者中安全降低蛋白尿症.
- HCQ的有效性与其血液度具有积极的相关性.
- 确定最佳的HCQ血度可以提高Igan的治疗结果.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
71
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
71
01:14Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
201
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
201
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
117
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
117
01:25Antihypertensive Drugs: Direct Renin Inhibitors
528
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
528